3-Hydroxy-3-methylglutaryl-coenzyme A reductase inhibitor (pravastatin) inhibits endothelial cell proliferation dependent on G1 cell cycle arrest - Asakage,M.; Tsuno,N.H.; Kitayama,J. (Anticancer Drugs, 2004)